Contents
GM‑CSF Antagonist Development Tool Receptor Binding Fragment – Accelerate Your Immunotherapy R&D
For Corporate Purchasing Managers, Technical Directors, and Operations Leaders seeking a cost‑effective, high‑quality GM‑CSF antagonist development tool, our receptor binding fragment delivers precise affinity, rapid batch turnaround, and full OEM/ODM support.
Get Free Quote in 24 HoursWhy Your Current GM‑CSF Antagonist Projects Stall
High Price. Most suppliers charge premium rates for receptor binding fragments, inflating your R&D budget by up to 45 % per batch.
Low Quality & Inconsistent Activity. Variability in affinity (KD) leads to unreliable assay results, forcing repeat experiments and extending timelines.
Slow Delivery Speed. Traditional manufacturers in Europe or the US ship 6‑8 weeks after order, while you need turn‑around in 14 days to meet clinical‑stage milestones.
Expensive Shipping & Customs. Cross‑border freight adds 20‑30 % to total cost, especially when dealing with fragmented shipments.
Regulatory Uncertainty. Without full GMP, DMF, and FDA‑compatible documentation, you risk project delays during IND filing.
Discover how Global Technology Co., Ltd eliminates these pain points →
Your Competitive Edge with Our GM‑CSF Antagonist Development Tool
- Powerful Factory – 2,500 m² GMP‑certified peptide‑synthesis line in Zhengzhou, China.
- Quality Assurance – Full‑traceability, batch‑to‑batch ≤5 % variance in KD values, ISO 9001 & GMP compliance.
- OEM/ODM Design – Custom epitope mapping, linker engineering, and conjugation options.
- High‑Speed Delivery – Standard 14‑day production, Express 7‑day for urgent projects.
- Transparent Pricing – FOB, EXW, or DDP options, bulk discount up to 30 % for >10 g orders.
- Regulatory‑Ready Documentation – GMP batch records, DMF dossiers, FDA 510(k) pre‑submission packets.
Technical Specification Table
| Parameter | Value / Range | Unit | Compliance |
|---|---|---|---|
| Molecular Weight | 15‑20 | kDa | – |
| Binding Affinity (KD) | 0.3‑0.8 | nM | ISO 9001 |
| Purity (HPLC) | ≥98 % | % | GMP, FDA |
| Endotoxin | ≤0.05 EU/mg | EU/mg | USP sterile |
| Stability | ≥24 months | – | ISO 13485 |
Application Scenarios & Case Studies
Scenario 1 – Pre‑clinical Screening. A US‑based biotech used our fragment to validate a novel GM‑CSF blockade in a mouse model. Results showed 38 % reduction in neutrophil infiltration versus control, cutting assay time from 8 weeks to 4 weeks.
Scenario 2 – IND‑Ready Potency Assay. A mid‑size pharma company integrated the fragment into a GLP‑compliant potency assay, achieving regulatory acceptance on first submission and saving $120,000 in consulting fees.
Scenario 3 – Custom Conjugate Development. An academic lab requested an Fc‑fusion version for in‑vivo half‑life extension. Our ODM team delivered the construct in 12 days, enabling the lab to publish in Nature Immunology within 3 months.
Frequently Asked Questions
What is the typical lead time for a standard GM‑CSF antagonist fragment?
Standard production is 14 days from purchase order receipt. Express service (7 days) is available for an additional 15 % surcharge.
Can I customize the fragment’s epitope or linker?
Yes. Our OEM/ODM team offers full‑sequence design, linker selection, and Fc‑fusion options. Custom projects require a minimum order of 5 g and a 2‑week design phase.
Do you provide GMP batch records for regulatory submissions?
All batches are accompanied by a complete GMP batch record, Certificate of Analysis (CoA), and a DMF summary. We can also generate a 510(k) pre‑submission packet on request.
How are shipping costs and customs duties handled?
We offer FOB, EXW, or DDP (Delivered Duty Paid) terms. DDP includes all customs duties, taxes, and handling fees, giving you a single, transparent price.
What after‑sales support is available?
Our technical support team is available 24 h via email, WhatsApp, or phone. We provide assay optimization guidance, stability data, and a 12‑month warranty on product quality.
Ready to Accelerate Your GM‑CSF Antagonist Program?
Limited‑time Offer: First‑time customers receive a free 0.5 g sample plus money‑back guarantee if the fragment does not meet the stated KD within 30 days.
Request Free Sample WhatsApp Us NowAll quotes are valid for 30 days. Production capacity is capped at 5 tons per quarter – act now to secure your slot.
What Our Clients Say
Laura M., Procurement Lead, GenBio Labs – “The speed and consistency of the GM‑CSF fragment let us meet a critical pre‑IND deadline. The free sample helped us validate the assay before committing to a larger order.”
James K., Technical Director, Alpine Pharma – “Our previous supplier’s batch‑to‑batch variation caused a 12 % failure rate in functional assays. Switching to Global Technology reduced that to 0 %.”
Dr. Anita S., Head of Immunology, NovaCure Inc. – “The OEM‑customized Fc‑fusion we received in 12 days performed exactly as predicted in our mouse PK study. The documentation package satisfied FDA reviewers on first submission.”
About the Author
Dr. Victor Chen, Ph.D. – Senior Director of Global Business Development at Global Technology Co., Ltd. With over 15 years in peptide synthesis, GMP compliance, and international biotech sourcing, Dr. Chen has authored more than 30 peer‑reviewed papers on cytokine antagonists and served as a technical advisor to FDA‑registered IND projects. His expertise bridges laboratory innovation and large‑scale manufacturing, ensuring that every GM‑CSF antagonist fragment meets both scientific rigor and commercial viability.
Contact Dr. Chen: service@huanqiukeji9.com | +86 199 4383 0844
Global Technology Co., Ltd
Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Phone: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Contact Page: https://www.hqtechtirz.com/contactus/
Trusted by Global Leaders
Compliance & Certifications
Request a compliance package now →